Peggy Crowder

Peggy Crowder is currently the Associate Director of Quality for Cell & Gene Therapy at AstraZeneca, where they focus on enhancing patient quality of life through rigorous quality oversight in Apheresis, Cryopreservation, and Infusion Centers. Prior to this role, they served in various positions at the American Red Cross from 2010 to 2016, gaining extensive experience in client relationship management and therapeutic solutions. Peggy’s dedication to innovative cellular therapies aims to tackle complex clinical challenges while collaborating with cross-functional teams to set new benchmarks in the biopharmaceutical sector. Currently, they are pursuing further education at The George Washington University.